Annual report pursuant to Section 13 and 15(d)

Net Loss Per Share (Details) - Schedule of Outstanding Shares Potentially Dilutive Securities

v3.24.1
Net Loss Per Share (Details) - Schedule of Outstanding Shares Potentially Dilutive Securities - shares
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive Securities 176,044,446 6,126,863
Options to purchase common stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive Securities 10,302,086 1,342,670
Warrants to purchase common stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive Securities 4,784,193 4,784,193
Warrants to purchase convertible preferred stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive Securities 160,958,167